521 related articles for article (PubMed ID: 34073185)
41. The ether lipid precursor hexadecylglycerol protects against Shiga toxins.
Bergan J; Skotland T; Lingelem AB; Simm R; Spilsberg B; Lindbäck T; Sylvänne T; Simolin H; Ekroos K; Sandvig K
Cell Mol Life Sci; 2014 Nov; 71(21):4285-300. PubMed ID: 24740796
[TBL] [Abstract][Full Text] [Related]
42. Shiga Toxin (Stx) Classification, Structure, and Function.
Melton-Celsa AR
Microbiol Spectr; 2014 Aug; 2(4):EHEC-0024-2013. PubMed ID: 25530917
[TBL] [Abstract][Full Text] [Related]
43. A Conformational Shift in the Dissociated Cholera Toxin A1 Subunit Prevents Reassembly of the Cholera Holotoxin.
Taylor M; Curtis D; Teter K
Toxins (Basel); 2015 Jul; 7(7):2674-84. PubMed ID: 26266549
[TBL] [Abstract][Full Text] [Related]
44. A verotoxin 1 B subunit-lambda CRO chimeric protein specifically binds both DNA and globotriaosylceramide (Gb(3)) to effect nuclear targeting of exogenous DNA in Gb(3) positive cells.
Facchini LM; Lingwood CA
Exp Cell Res; 2001 Sep; 269(1):117-29. PubMed ID: 11525645
[TBL] [Abstract][Full Text] [Related]
45. Shiga toxin and its use in targeted cancer therapy and imaging.
Engedal N; Skotland T; Torgersen ML; Sandvig K
Microb Biotechnol; 2011 Jan; 4(1):32-46. PubMed ID: 21255370
[TBL] [Abstract][Full Text] [Related]
46. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains.
Katagiri YU; Mori T; Nakajima H; Katagiri C; Taguchi T; Takeda T; Kiyokawa N; Fujimoto J
J Biol Chem; 1999 Dec; 274(49):35278-82. PubMed ID: 10575015
[TBL] [Abstract][Full Text] [Related]
47. Cholera and Shiga toxin B-subunits: thermodynamic and structural considerations for function and biomedical applications.
Pina DG; Johannes L
Toxicon; 2005 Mar; 45(4):389-93. PubMed ID: 15733559
[TBL] [Abstract][Full Text] [Related]
48. Shiga toxins: from structure and mechanism to applications.
Chan YS; Ng TB
Appl Microbiol Biotechnol; 2016 Feb; 100(4):1597-1610. PubMed ID: 26685676
[TBL] [Abstract][Full Text] [Related]
49. Gangliosides that associate with lipid rafts mediate transport of cholera and related toxins from the plasma membrane to endoplasmic reticulm.
Fujinaga Y; Wolf AA; Rodighiero C; Wheeler H; Tsai B; Allen L; Jobling MG; Rapoport T; Holmes RK; Lencer WI
Mol Biol Cell; 2003 Dec; 14(12):4783-93. PubMed ID: 13679513
[TBL] [Abstract][Full Text] [Related]
50. Verotoxins inhibit the growth of and induce apoptosis in human astrocytoma cells.
Arab S; Murakami M; Dirks P; Boyd B; Hubbard SL; Lingwood CA; Rutka JT
J Neurooncol; 1998 Nov; 40(2):137-50. PubMed ID: 9892096
[TBL] [Abstract][Full Text] [Related]
51. Toxicity and immunogenicity of a verotoxin 1 mutant with reduced globotriaosylceramide receptor binding in rabbits.
Bast DJ; Brunton JL; Karmali MA; Richardson SE
Infect Immun; 1997 Jun; 65(6):2019-28. PubMed ID: 9169727
[TBL] [Abstract][Full Text] [Related]
52. The intracellular voyage of cholera toxin: going retro.
Lencer WI; Tsai B
Trends Biochem Sci; 2003 Dec; 28(12):639-45. PubMed ID: 14659695
[TBL] [Abstract][Full Text] [Related]
53. Retroviral transfection of Madin-Darby canine kidney cells with human MDR1 results in a major increase in globotriaosylceramide and 10(5)- to 10(6)-fold increased cell sensitivity to verocytotoxin. Role of p-glycoprotein in glycolipid synthesis.
Lala P; Ito S; Lingwood CA
J Biol Chem; 2000 Mar; 275(9):6246-51. PubMed ID: 10692420
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of endoplasmic reticulum-associated degradation in CHO cells resistant to cholera toxin, Pseudomonas aeruginosa exotoxin A, and ricin.
Teter K; Holmes RK
Infect Immun; 2002 Nov; 70(11):6172-9. PubMed ID: 12379695
[TBL] [Abstract][Full Text] [Related]
55. Inhibitory activity of Bifidobacterium longum HY8001 against Vero cytotoxin of Escherichia coli O157:H7.
Kim SH; Yang SJ; Koo HC; Bae WK; Kim JY; Park JH; Baek YJ; Park YH
J Food Prot; 2001 Nov; 64(11):1667-73. PubMed ID: 11726142
[TBL] [Abstract][Full Text] [Related]
56. Differential tissue targeting and pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Rutjes NW; Binnington BA; Smith CR; Maloney MD; Lingwood CA
Kidney Int; 2002 Sep; 62(3):832-45. PubMed ID: 12164865
[TBL] [Abstract][Full Text] [Related]
57. Intracellular drug delivery: Potential usefulness of engineered Shiga toxin subunit B for targeted cancer therapy.
Luginbuehl V; Meier N; Kovar K; Rohrer J
Biotechnol Adv; 2018; 36(3):613-623. PubMed ID: 29432805
[TBL] [Abstract][Full Text] [Related]
58. A therapeutic chemical chaperone inhibits cholera intoxication and unfolding/translocation of the cholera toxin A1 subunit.
Taylor M; Banerjee T; Navarro-Garcia F; Huerta J; Massey S; Burlingame M; Pande AH; Tatulian SA; Teter K
PLoS One; 2011 Apr; 6(4):e18825. PubMed ID: 21526142
[TBL] [Abstract][Full Text] [Related]
59. Membrane cytosolic translocation of verotoxin A1 subunit in target cells.
Tam PJ; Lingwood CA
Microbiology (Reading); 2007 Aug; 153(Pt 8):2700-2710. PubMed ID: 17660434
[TBL] [Abstract][Full Text] [Related]
60. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: comparison of a supported bilayer film and liposomes.
Arab S; Lingwood CA
Glycoconj J; 1996 Apr; 13(2):159-66. PubMed ID: 8737240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
